The largest community of pharma leaders

Celsius Therapeutics Announces Executive Leadership Team Appointments

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Celsius Therapeutics, a company translating single-cell genomic insights into precision therapeutics for patients with autoimmune diseases and cancer, today announced its first key leadership appointments. Greg Ryslik, Ph.D., has joined as chief data officer, and Michael Boretti, Ph.D., has joined as chief business officer. “Over the past year, we have been building our team and assembling an integrated, industrial-scale platform that combines single-cell geno….





Recent Articles